TARDBP and glioma: In glioma, SNHG12 targeting of miR-101-2 leads to enhanced cell growth (134), malignant progression via TDP43 (TAR DNA-binding protein 43) (135), and enhanced proliferation/migration capacity due to the association with the Hu antigen R (136).